Pauda mauʻu bale

Hua'ōlelo nui: ka pauka mauʻu bale;ʻO ka pauka wai mauʻu bale

[Inoa Latina] Hordeum vulgare L. .

[Plant Source] Mauʻu Barley

[Solubility] Hoʻoheheʻe manuahi i ka wai

[Hōʻike] pauda ʻōmaʻomaʻo maikaʻi

Mahele Meakanu: Mauu

[Nui ʻāpana]100 Mesh-200Mesh

[Nalo ma ka maloʻo] ≤5.0%

[Mea Kaumaha] ≤10PPM

[Ke koena pesticide] EC396-2005, USP 34, EP 8.0, FDA

[Storage] E kūʻai ma kahi maloʻo a maloʻo, e mālama i ka mālamalama pololei a me ka wela.

[Ke ola mau] 24 Mahina

[Package] Hoʻopili ʻia i loko o nā pahu pahu pepa a me ʻelua ʻeke plastik i loko.

[Kapaona paona] 25kgs/pahu

[He aha ka Barley?]

He mauu makahiki ka bale. ʻO ka mauʻu bale ka lau o ka mea kanu bale, e kūʻē i ka palaoa. Hiki iā ia ke ulu ma kahi ākea o nā kūlana climatic. ʻOi aku ka waiwai o ka mauʻu barley inā ʻohi ʻia i ka wā ʻōpiopio.

[Pehea ka hana?]

Hiki i ka fiber i loko o ka bale ke hoʻohaʻahaʻa i ka cholesterol a me ke koko i ka poʻe me ka cholesterol kiʻekiʻe. Hiki i ka bale ke hoʻemi i ke kō koko a me ka pae o ka insulin. Me he mea lā ke lohi nei ka ʻōpū o ka bale. Hiki i kēia ke kōkua i ka paʻa ʻana o ke kō koko a hoʻoulu i ka manaʻo o ka piha ʻana, hiki ke kōkua i ka mālama ʻana i ka ʻai.

[Hana]

1. Hoʻonui i ka ikehu maoli

2. Nui i nā antioxidants

3. Hoʻomaikaʻi i ka digestion & regularity

4. Hoʻomākaʻikaʻi i ke kino o loko

5. Kōkua i ke kūkulu hou ʻana i ka ʻōnaehana pale

6. Hāʻawi i nā poloka kūkulu maka no ka lauoho, ka ʻili a me nā kui

7. Loaʻa nā waiwai detoxification a me ka hoʻomaʻemaʻe

8. Loaʻa nā mea anti-inflammatory

9. Hoʻoikaika i ka noʻonoʻo maopopo

10. Loaʻa nā waiwai anti-kahiko

ʻO Jose S. Pulido, MD, Kumu o Opthalmology & Molecular Medicine, Mayo Clinic College of Medicine a me Alan D. Marmorstein, Ph.D., Professor of Ophthalmology, Mayo Clinic College of Medicine e kūkākūkā i ke koʻikoʻi o ka ho'āʻo genetic i kaʻikeʻana i ka macular degeneration. ʻEkolu mau hihia i wehewehe ʻia i kapa ʻia ʻo Adult Onset Foveomacular Dystrophy, Macular Degeneration, a me ka maʻi maikaʻi loa. Hiki ke hoʻohana ʻia ka hoʻāʻo genetic e hana i kēia mau ʻike a aia nā mea noiʻi ma ka paepae o nā lāʻau lapaʻau hou a hoihoi. I loko o nā makahiki i hala iho nei, ua komo ka hale hana ʻo Kauka Marmorstein i ka noiʻi ʻana i nā ʻano hoʻohālike stem cell o Best Disease a me nā maʻi degenerative retinal. Hiki ke loaʻa nā kikoʻī ma ka pūnaewele NIH. Ke hōʻiliʻili ʻia nei ka DNA me nā fibroblasts ʻili mai nā maʻi me nā maʻi maikaʻi loa ʻo Vitelliform Dystrophy Autosomal Recessive Bestrophinopathy, autosomal dominant vitreoretinal choroidopathy, a me retinitis pigmentosa ma muli o ka hoʻololi ʻana i BEST1. Hoʻonohonoho hou ʻia nā ʻili fibroblasts i loko o nā pūnaewele pluripotent i hoʻokomo ʻia i hiki ke hoʻokaʻawale ʻia i loko o nā ʻāpana epithelial pigment retinal. ʻO kēia ke kelepona kahi i hōʻike ʻia ai ʻo Bestrophin, ka huahana o ka gene BEST1 a ma laila ka pilikia pathogenic i hopena i kēia mau maʻi. Ke hoʻomaka nei nā hoʻokolohua lapaʻau me ka hoʻohana ʻana i ka iPS cell derived retinal pigment epithelial cell no ka mālama ʻana i ka Macular Degeneration pili makahiki. ʻAe ia i ka noʻonoʻo ʻana i ke kaʻina hana like e mālama ai i ka maʻi maikaʻi loa a me nā pākeke Vitelliform Macular Dystrophy, Autosomal Recessive Bestrophinopathy a me nā hiʻohiʻona o nā maʻi hiki ke hana ʻia i nā maʻi i loko o ka hale hana. Hiki i kēia ke kōkua i ka hoʻomaopopo ʻana i nā kaʻina hana e hoʻoulu ai i ka maʻi a ʻae i ka hoʻāʻo ʻana i nā pūhui therapeutic hiki ke hoʻoholo inā he hopena ko lākou i kēia mau maʻi kūikawā.

No ka 'ike hou aku, e kipa: https://www.mayoclinic.org/departments-centers/ophthalmology?mc_id=us&utm_source=youtube&utm_medium=sm&utm_content=video&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100504

https://www.ihealthtube.com
Kūkākūkā ʻo Ivan Rusilko ka meaʻai meaʻai a me ke olakino olakino i ke kuleana nui o ka nitric oxide i ka hoʻomaikaʻi ʻana i ke olakino. Kūkākūkā ʻo Kauka Rusilko i nā pōmaikaʻi ʻaʻole i nā kāne wale nō, akā i nā wahine pū kekahi.